hey all
thought id open up this thread; Aroa posted their end of year results 1st of July and they were good. exceeded growth targets. they seem a little bigger than PNV having about 220 staff, simialr key focus of the US, wound carbut aroa is using sheep foregut products vs Polynovo synthetics
you cant dispute their revenue growth; its in NZD va PNV in AUD, very similar in number. id hazard a guess Aroa is oerhaps growing more quickly
they have 6 commercial products through vs PNVs one at this point
aroa are solutions for hernia, breast and diabetic ulcers as well as complex wounds
opening up debate to talk about PNV vs Aroa
coming down to Aroa and Polynovo; Avita seems out of the race for bow
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.095(3.56%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.62 | $2.53 | $2.622M | 1.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 7061 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 44003 | 45 |
View Market Depth
| Last trade - 13.08pm 25/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |